Projects

Corneal bioimpression for advanced surgical reparation

Medication using specialized cell‐targeted lipid nanoparticle encapsulation in neuromuscular disorders

Hybrid iPSC bioartificial liver

Bioengineered stem cell-derived retinal cells and tissue for cell therapy

Personalised phage therapy against gram-negative multidrug resIstant organisms

New Autonomously Replicating Non-Viral Vectors

ACCelerating Research for Early Development of Innovative Antibodies

Multidisciplinary approach to stimulate the bioproduction and engineering of Gram+ bacteria’s Extracellular Vesicles (EVs) for therapeutic applications to treat inflammation

Bioengineering of next-generation skin substitutes for cutaneous regeneration

Improving the whole chain of large scale AAV bioproduction through disruptive technologies

Development of biotherapies based on the local delivery of therapeutic RNAs by hybrid functionalized extracellular vesicles (EVs) for musculoskeletal regeneration

Development of breakthrough technologies in gene editing

Generation of iChondrocytes to regenerate articular cartilage

Genomic editing of stable universal pluripotent stem cells for allogeneic cell biotherapies

Innovative approaches for quality control to support the industrial deployment of future gene therapy products.

New generation of mRNA-based vaccines

From engineering of iPS-derived mesenchymal stromal cell-derived extracellular vesicles to clinical translation

B-cell genetic engineering for new therapeutic and vaccine modalities